West Increases Equity Stake in Daikyo Seiko, Ltd. - Extending the Companies' Longstanding Partnership in Injectable Drug Delivery
West and Daikyo have long-standing agreements which include a distribution agreement, by which West distributes and markets Daikyo products throughout the world, on an exclusive basis, as well as a technology exchange and cross license agreement, which grants each party certain exclusive intellectual property rights for the manufacture of products covered by the relationship. Additionally, Daikyo has distribution rights of West products within
"West and Daikyo have formed an exceptional, long-term partnership to supply critically important components for the containment and delivery of injectable medicines," said
"Daikyo specializes in improving product quality to the highest level possible—always seeking to develop innovative components and solutions that can lead us to absolute quality," said
This press release contains forward-looking statements within the meaning of the federal securities laws which are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as "may," "should," "could," "expects," "intends," "plans," "anticipates," "believes," "estimates," "predicts," or "potential" or the negative of these words and phrases or similar words or phrases, which are predictions of or indicate future events or trends and which do not relate solely to historical matters. Examples of these forward-looking statements include (but are not limited to) statements with respect to future collaborations and products. While forward-looking statements reflect West's good faith beliefs, assumptions and expectations, they are not guarantees of future performance. Furthermore, except as required by law, West disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions, new information or other changes. Known material risks, uncertainties and other factors that can affect future results are discussed or incorporated by reference in periodic reports under the Securities Exchange Act of 1934, as amended, filed by West from time to time with the
Trademarks and registered trademarks are the property of
View original content to download multimedia:http://www.prnewswire.com/news-releases/west-increases-equity-stake-in-daikyo-seiko-ltd--extending-the-companies-longstanding-partnership-in-injectable-drug-delivery-300939587.html
Investor Relations Contact: Quintin Lai, Investor Relations, West, + 1-610-594-3318, Quintin.Lai@westpharma.com. Media Contact: Emily Denney, Global Communications, West, + 1-610-594-3035, Emily.Denney@westpharma.com.